BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:Over the past year\, the Myasthenia Gravis landscape has trans formed from a once-sparse market into a highly competitive\, multi-billio n-dollar arena\, driven by breakthroughs in FcRn inhibition\, complement targeting and B-cell modulation. This surge has sparked growing interest in applying these approaches to adjacent neuromuscular and peripheral ner ve disorders\, yet critical gaps in disease biology\, patient stratificat ion and biomarker validation continue to limit clinical success. \;\n \nThe Autoimmune Neuromuscular and Nerve Disorders Drug Development Summi t is the first industry-led forum dedicated to transforming the MG\, CIDP \, GBS and MMN treatment landscapes\, bringing together biopharma leaders to tackle the mechanistic and translational challenges shaping this rapi dly evolving space. \;\n\nThis meeting is uniquely positioned to addr ess these challenges. Unlike pathway-specific or clinician-led events\, i t is indication-focused\, mechanism-driven and tailored exclusively to dr ug developers\, enabling deeper discussion on pathophysiology\, different iation and translational strategy. \;\n\nAs competition intensifies a nd more companies enter the space\, success will depend on how well you u nderstand\, and exploit\, the underlying biology. Join your peers to de-r isk development\, identify new opportunities and gain a competitive edge in one of the fastest-moving areas of immunology and neurology.\n\nURLs:W ebsite: \;https://go.evvnt.com/3581832-0?pid=185Tickets: \;https: //go.evvnt.com/3581832-1?pid=185Brochure: \;https://go.evvnt.com/3581 832-3?pid=185\n\nPrices:Industry Pricing - Conference + Workshop Day: USD 4397.00\,Industry Pricing - Conference Only: USD 3099.00\,Academic Prici ng - Conference + Workshop Day: USD 3797.00\,Academic Pricing - Conferenc e Only: USD 2699.00\,Vendor Pricing - Conference + Workshop Day: USD 5297 .00\,Vendor Pricing - Conference Only: USD 3799.00\n\nSpeakers: \;Jes sica Van Baaren\, Senior Scientist and Project Manager\, Neuromuscular Tr anslational Biology\, UCB\, Karen Lynch\, Global Senior Director\, Medica l\, Sanofi\, Tarek Samad\, Senior Vice President and Global Head\, Resear ch\, Lundbeck\, Sanjay Rakhade\, Executive Medical Director\, Clinical De velopment\, Alexion Pharmaceuticals\, Julian Chandler\, Associate Directo r\, Alexion Pharmaceuticals\, Beatrix Bartok\, Vice President\, Clinical Development\, Biogen\, Tony Shock\, Director\, UCB\, Martin Kolev\, Direc tor\, Complement Science\, Apellis Pharmaceuticals\, Lien Dejager\, Head\ , Translational Science\, argenx\, Bianca Balbino\, Senior Clinical Scien tist\, argenx\, Salma Merchant\, Biology Research Scientist\, Alnylam Pha rmaceuticals\, David Ngai\, Scientist\, Biology\, Alnylam Pharmaceuticals \, David Pirman\, Senior Vice President and Head of Discovery\, Biohaven\ , Jeremy Sokolove\, Chief Medical Officer\, Vor Biopharma\, Dina Schneide r\, Vice President and Head of Discovery\, Cartesian Therapeutics\, Gil W olfe\, Distinguished Professor\, SUNY\, University at Buffalo\, Pushpa Na rayanaswami\, Professor of Clinical Neurology\, Harvard Medical School\, Vice-Chair\, Clinical Operations\, Department of Neurology\, Beth Israel Deaconess Medical Center\, Richard Blumberg\, Professor of Medicine\, Har vard Medical School\n\nCategory: \;Conferences | Science\, Health and Medicine | Pharmaceuticals\n\nDate and Time: \;21st July 2026 at 9:0 0 am to 23rd July 2026 at 5:00 pm\n\nVenue details: \;Hotel AKA Back Bay\, 154 Berkeley Street\, Boston\, Massachusetts\, 02116\, United State s\n DTEND:20260723T170000 DTSTAMP:20260512T214301Z DTSTART:20260721T090000 LOCATION:Hotel AKA Back Bay\, 154\, Berkeley Street\, Boston\, Massachuset ts\, 02116\, SEQUENCE:0 SUMMARY:Over the past year\, the Myasthenia Gravis landscape has transform ed from a once-sparse market into a highly competitive\, multi-billion-do llar arena... UID:9d476769-ec79-464a-9fc9-67b760df5c62 END:VEVENT END:VCALENDAR